Clinical Trial Update: Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update for enzastaurin in prostate cancer patients who have undergone hormonal therapy and chemotherapy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-25